vimarsana.com

Page 2 - உயிரி தொழில்நுட்பவியல் அறிவியல் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

한길학교와 국립한경대학교가 함께하는 2021 생명공학 과학 교실

한길학교와 국립한경대학교가 함께하는 2021 생명공학 과학 교실
ilyo.co.kr - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from ilyo.co.kr Daily Mail and Mail on Sunday newspapers.

資金加速回流 生醫基金潛力大 - 財經

資金加速回流 生醫基金潛力大 - 財經
chinatimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from chinatimes.com Daily Mail and Mail on Sunday newspapers.

後疫情時代景氣復甦激勵股市 生技、科技基金最受青睞 | Anue鉅亨

基金 facebook comment 富蘭克林投顧指出,上半年的復甦行情吸引資金湧入先前疫情衝擊的景氣循環股,但不影響投資人對科技股的情有獨鍾,近期通膨、升息疑慮消退後資金旋即歸隊成長股,有創新題材加持的科技、生技醫療型基金單月漲幅逾 7%。 以富蘭克林「國民 e 帳戶」來說,存量前五大的基金,有三檔是美股為主,包括富蘭克林坦伯頓生技領航、科技基金,及富蘭克林高科技基金,此投資意向也呼應境外基金觀測站的統計數據。 另外,科技重鎮的美股基金同樣受國人歡迎,今年前五個月淨流入 1,120 億元,是最吸金的單一國家型基金類別。 而另一檔在美股中再加入部分美國高收益債以求平衡風險的富蘭克林坦伯頓穩定月收益基金的投資部位也名列「國民 e 帳戶」第五,顯示有不少投資人採取股債兼備、較為穩健的策略因應多變的市場氣

General Biology Lecturer job with WENZHOU - KEAN UNIVERSITY

General Biology Lecturer Position  Wenzhou-Kean University (WKU), located in Wenzhou, China, one of three Sino-American universities along with NYU Shanghai and Duke Kunshan  University, is approved by the Ministry of Education of China. Launched in 2012, WKU offers a unique model of higher education in partnership with Kean University, a comprehensive, public university in the state of New Jersey that is accredited by the Middle States Commission on Higher Education. WKU sits on approximately 500 beautiful acres and currently enrolls 2,900 undergraduate students, and it is now in the midst of a rapid growth that will bring enrollment to 7,000 students within the next five years. All instruction is in English and all curriculum is provided by Kean University. In addition to its current 18 undergraduate programs, WKU has been approved by the Ministry of Education for offering 8 Master’s and 3 doctorate programs. Wenzhou is one of the most vibrant and economically advanced develop

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.